Search results
Cordis. In 2021, H&F acquired Cordis, a leading provider of cardiovascular and endovascular medical devices. Founded in 1966, the Company has a long history of innovation in high-quality and minimally-invasive cardiovascular technology.
Mar 12, 2021 · Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman. DUBLIN, Ohio. Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assumption of certain liabilities and ...
People also ask
Did Cardinal Health sell CORDIS to Hellman & Friedman?
Will Hellman & Friedman spin Cordis into a medtech company?
Who owns Cordis medical devices?
Why did H&F buy Cordis?
Aug 2, 2021 · DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F.
Hellman & Friedman, LLC is a U.S.-based global private equity firm with a distinctive investment approach focused on large-scale equity investments in high quality growth businesses.
Mar 15, 2021 · Now, Hellman & Friedman plan to spin Cordis into a mainstay provider of minimally invasive cardiovascular devices—and it’s enlisting the help of two medtech investment and innovation firms to...
- Conor Hale
Oct 17, 2022 · Cordis is backed by private equity firms Hellman & Friedman and KKR. For more information, visit www.cordis.com. About MedAlliance. MedAlliance is headquartered in Nyon, Switzerland.
DUBLIN, Ohio. Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health’s Cordis business to H&F. The sale price of approximately $1 billion includes the buyer’s assumption of certain liabilities and the seller’s retention of certain working capital accounts.